Newly CE Marked Stent Offers Drug Protection After Polymer Coating Has Gone.

Micell’s MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System is a thin-strut stent that features elimination of the coating from the stent in 45-60 days and the complete absorption of the polymer coating within 90 days. Uniquely it provides local drug delivery both during and after the period of polymer absorption, thereby eliminating long-term polymer exposure, a potential cause of delayed healing and late adverse events.

FDA Clears GE Healthcare’s Brivo Plus imaging C-arm

GE Healthcare has gained FDA 510(k) clearance for its latest Brivo Plus C-arm, which is now available in the US. The pitch for the newly cleared device is that with legacy OEC image quality and ease-of-use, the affordability and reliability of this new Brivo C-arm will offer a high quality, economically attractive option for basic surgical imaging.

FDA Clearance and CE Mark For Medtronic’s New Peripheral Angioplasty Balloon

Peripheral Vascular Disease therapies include the use of percutaneous transluminal angioplasty(PTA) using a balloon catheter. While recent news has been all about the race to (U.S.) market for drug eluting varieties, Medtronic is no doubt hoping its Pacific Plus device is sufficiently feature-packed to take a chunk of the market until their drug eluter gains approval.

CE Mark For ArtVentive’s Endoluminal Occlusion Device

ArtVentive Medical Group, Inc. has received European CE Mark certification for the ArtVentive EOS™ Peripheral Vascular Endoluminal Occlusion system. The company is very coy about sharing its IP, to the extent that we’re not really sure how it works. But studies suggest it’s 100% effective, which is good enough for the CE brigade.

Most read

Latest

^